Mustang Bio Company

Mustang Bio is a clinical-stage biopharmaceutical company .
Technology:
CAR-T, CAR-T therapy
Industry:
CAR-T, Public
Headquarters:
New York, New York, United States
Founded Date:
2015-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
4
Total Funding:
204300000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-03-08
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership